Merck stock rises as markets wobble — what to watch before the Feb. 3 earnings call

Merck & Co shares climbed roughly 1.2% to $109.64 by Friday afternoon, finding footing after a volatile week for U.S. stocks. The health care sector showed strength, with the Health Care Select Sector SPDR ETF edging up about 0.6%, despite the broader market slide—the SPDR S&P 500 ETF dipped roughly 0.5%. Johnson & Johnson held steady, while Pfizer and Eli Lilly posted gains.

Earnings Reports · NYSE:MRK · Pharmaceuticals · Stock Market
Merck stock slips after report says MRK stepped back from Revolution Medicines talks

Merck stock slips after report says MRK stepped back from Revolution Medicines talks

Merck & Co shares slipped 0.6% to $107.57 in Monday afternoon trading after reports surfaced that the U.S. drugmaker ended talks to acquire cancer-drug developer Revolution Medicines. According to Reuters, which followed an initial report by the Wall Street Journal, negotiations stalled over price disagreements. The potential deal, valued between $28 billion and $32 billion, would have granted Merck access to Revolution’s late-stage drug daraxonrasib, carrying an FDA fast-track review voucher to speed up future approvals. Neither company has issued a comment.
26 January 2026
··
Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer shares dropped roughly 1.9% to $25.62 Friday afternoon, underperforming the health-care sector as the stock went ex-dividend. The Health Care Select Sector SPDR Fund dipped about 0.5%, while the SPDR S&P 500 ETF Trust inched up around 0.1%. Merck slipped about 1%, and Moderna tumbled over 7%. Trading volume for Pfizer hit roughly 24.8 million shares.
23 January 2026
·····
Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

The Dow Jones Industrial Average rose in early trade on Wednesday, clawing back some ground a day after a sharp selloff, after President Donald Trump said he would not use force to acquire Greenland. At 9:38 a.m. ET, the Dow was up 203.56 points, or 0.42%, at 48,692.15. “That’s a sigh of relief,” said Art Hogan, chief market strategist at B Riley Wealth.
21 January 2026
·······
Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Merck & Co shares held steady on Tuesday following news that the company's personalized cancer vaccine, developed with Moderna, continued to lower the risk of melanoma recurrence and death when used alongside Keytruda. By 2:02 p.m. EST, Merck was down just 0.01% at $108.82, with the stock fluctuating between $107.06 and $109.11.
20 January 2026
····
Healthcare stocks slide into long weekend as XLV drops; J&J earnings loom

Healthcare stocks slide into long weekend as XLV drops; J&J earnings loom

U.S. healthcare stocks wrapped up the week as the S&P 500’s weakest sector, with the Health Care Select Sector SPDR Fund slipping 0.8% on Friday to $155.74. Anthony Saglimbene, chief market strategist at Ameriprise Financial, noted that “most investors will take that as a win,” given the market hovered near record highs despite a volatile week.
17 January 2026
······
Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

The Dow Jones Industrial Average dipped in early Friday trading, erasing a modest gain from the open as declines in healthcare and consumer sectors weighed on the index. Around 10 a.m. ET, the Dow was down 70.37 points, or 0.14%, at 49,372.07. The S&P 500 edged up 0.07%, while the Nasdaq Composite climbed 0.26%. Among the Dow's biggest losers were Salesforce, Merck, and UnitedHealth, with Nvidia bucking the trend and moving higher.
16 January 2026
········
1 2 3 4 5 … 8
Follow on Google News
Add as preferred source Open in Google News